Results 51 to 60 of about 5,534 (181)

Society for Maternal‐Fetal Medicine Consult Series #76: Cancer in pregnancy

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Approximately one in 1000 pregnancies is complicated by the diagnosis of cancer each year, and the incidence of cancer among reproductive‐age individuals is increasing. Management of a pregnant person with cancer can be complex and warrants a multidisciplinary approach to care.
Society for Maternal‐Fetal Medicine (SMFM)   +6 more
wiley   +1 more source

Comparative Efficacy of Ribosome-Inactivating Protein-Containing Immunotoxins in 2D and 3D Models of Sarcoma

open access: yesToxins
Sarcomas are very complex and clinically challenging mesenchymal tumors. Although the standard therapeutic approach has improved the 5-year survival rate, many patients experience local relapses and/or distant metastases.
Giulia Calafato   +3 more
doaj   +1 more source

Identifying Distinct Molecular Subtypes and Establishing a Prognostic Framework for DLBCL Patients via Multiomics Analysis and Machine Learning Approaches

open access: yesHuman Mutation, Volume 2026, Issue 1, 2026.
Diffuse large B‐cell lymphoma (DLBCL) is characterized by profound heterogeneity that underpins varied clinical outcomes. To decipher this complexity, we performed an integrated single‐cell and genomic analysis. Using scRNA‐seq data (GSE182434), we identified six distinct malignant B‐cell subclusters (MB1‐MB6) within the DLBCL ecosystem.
Hongyu Shen   +7 more
wiley   +1 more source

Individually Specified Drug Immunoconjugates in Cancer Treatment

open access: yesThe International Journal of Biological Markers, 1989
Forty-three patients with disseminated refractory malignancies each received an individually-specified combination of either Adriamycin (24 patients) or mitomycin-C (19 patients) conjugated murine monoclonal antibodies. Tumors were typed using a panel of
R.K. Oldham   +6 more
doaj   +1 more source

Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases

open access: yesAntibodies, 2018
Accumulating evidence suggests that tissue factor (TF) is selectively expressed in pathological angiogenesis-dependent as well as macrophage-associated human diseases.
Zhiwei Hu
doaj   +1 more source

An Overview of Emerging Trends in Targeted Therapy of Triple‐Negative Breast Cancer

open access: yesInternational Journal of Breast Cancer, Volume 2026, Issue 1, 2026.
Triple‐negative breast cancer (TNBC) is a biologically diverse, highly aggressive class of breast cancer defined by the absence of estrogen, progesterone, and HER2 receptors. It accounts for approximately 10%–20% of all invasive breast cancers, and disproportionately affects women of younger ages and from minority groups.
Anuj Kumar   +2 more
wiley   +1 more source

Novel Bioconjugate Materials: Synthesis, Characterization and Medical Applications

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 31, December 8, 2025.
This review discusses the bioconjugation of novel materials grouped under “biological”, “hybrid” and “synthetic” categories. Medical applications ranging from cancer therapy and diagnostics to optogenetics and tissue engineering are explored, and conjugation trends are highlighted as a general guide. The review concludes with a comparison of techniques
Ellie Martin   +6 more
wiley   +1 more source

immunoconjugate

open access: yes
Citation: 'immunoconjugate' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13279 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
REIS E SOUSA CAETANO, SCHULZ OLIVER
openaire   +3 more sources

Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo‐Immunometabolic Therapy

open access: yesWIREs Nanomedicine and Nanobiotechnology, Volume 17, Issue 6, November/December 2025.
Schematic representation of nanoparticle‐mediated photothermal therapy (PTT) inducing anti‐tumor immune responses. Nanoparticles are administered to a tumor‐bearing mouse and accumulate at the tumor site. Upon laser irradiation, the nanoparticles generate reactive oxygen species (ROS) within cancer cells, leading to cellular apoptosis.
Alexander Chota   +3 more
wiley   +1 more source

Inter‐Nanoparticle FRET for Biosensing: Photophysics Versus Size

open access: yesAngewandte Chemie International Edition, Volume 64, Issue 39, September 22, 2025.
Förster resonance energy transfer (FRET) systems with luminescent nanoparticles (NPs) as donors and acceptors (inter‐NP FRET) combine unique photophysical properties with large sizes. This review discusses the influence of NP type, architecture, surface chemistry, and optical properties on FRET and the pros and cons of inter‐NP FRET for bioanalytical ...
Eduard Madirov   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy